I am thrilled to have a guest commentary this week on Carl Anderson's wonderful GXP Perspectives blog on recent changes in the clinical trials landscape in India. New rules and guidances emerging in recent months are all pointing - I believe - to an even stronger clinical trials enterprise in a country whose credentials are already very good. Please go on over to Carl's blog and take a look, make a comment. I'd love to get your thoughts.
Thanks very much indeed to Carl for his support.
No comments:
Post a Comment